Norwalk Virus 

  • Author: Zartash Zafar Khan, MD; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Jan 11, 2012
 

Background

Norwalk virus was officially renamed norovirus by the International Committee on Taxonomy of Viruses in 2002. The virions contain a single-stranded RNA molecule in round to hexagonal capsids that are 35-39 nm in diameter, with icosahedral symmetry. The surface structure of the capsid is a regular pattern with distinctive features and 32 cup-shaped depressions.[1, 2]

Norovirus was first recognized as a cause of gastroenteritis in 1972, when it was detected in stool samples collected from infected elementary school students and contacts during an outbreak in Norwalk, Ohio, in 1968. It was declared a member of the Caliciviridae family of viruses in 1993.[3] It is now considered the most common cause of epidemic nonbacterial gastroenteritis in the world.

In the 1970s and 1980s, typing of Norwalk-like virus (NLV) relied solely on immunologic methods involving human clinical samples as the source of antigens and antibodies. These methods had serious limitations in accuracy and reproducibility and never provided a reliable scheme for antigenic classification of strains. In the 1990s, however, newer molecular techniques to amplify, sequence, and express the genome of NLV strains allowed researchers to genetically and antigenically characterize NLV strains.[4]

The Norovirus genus contains more than 40 different strains that are divided into 5 genogroups based on sequence similarity. Viruses in genogroups I, II, and IV are primarily human pathogens, although genogroup II contains a porcine-specific virus. Viruses in genogroup III and V infect bovine and murine species, respectively. Each genogroup is further subdivided into genoclusters based on sequence similarity.[5]

The genome consists of single-stranded RNA of 7.3-7.7 kilobases. It encodes 3 open reading frames (ORFs). ORF 1 is the largest (approximately 1700 amino acids) and expressed as a nonstructural polyprotein precursor that is cleaved by the viral 3C-like protease. ORF 2 encodes the viral capsid (550 amino acids) and contains the shell and protruding domains. ORF 3 encodes a small basic protein of unknown function. See the image below.

The norovirus genomic structure and capsid domainsThe norovirus genomic structure and capsid domains.
Next

Pathophysiology

Noroviruses are transmitted person to person via direct contact, exposure to aerosols, or fecal–oral routes. Noroviruses are highly contagious, with infection requiring fever than 10 virions (ID50 = 10 virions), leading to disease in 50% of inoculated individuals. The virus is extremely stable in the environment and resists freezing temperatures, heat (up to 60˚C), disinfection with chlorine, acidic conditions, vinegar, alcohol, antiseptic hand solutions, and high sugar concentrations. The incubation period is approximately 1-2 days, and symptoms typically last 1-3 days (or longer in immunocompromised individuals). Viral shedding occurs for up to 3 weeks following infection.[6]

Noroviruses bind polymorphic histoblood group antigens (HBGAs) that putatively serve as receptors or cofactors for infection. Strains from different genoclusters bind various HBGAs: Genogroup I viruses preferentially bind blood group A and O antigens, while genogroup II viruses predominantly bind A and B antigens.[7] Individual norovirus strains may be capable of infecting only a subset of the human population, although the diverse binding profiles found within genogroup I and genogroup II viruses likely collectively make nearly all individuals susceptible to norovirus infection.[6] Recurrent infections can occur throughout life because of the great diversity of norovirus strains and the lack of cross-strain or long-term immunity.

Infection is characterized by damage to the microvilli in the small intestine. Upon microscopic investigation, villi are found to be blunted, although the mucosa and epithelium remain intact.[8] A recent study demonstrated increased epithelial cell apoptosis and damage to tight junction proteins.[9] Diarrhea is induced by D-xylose and fat malabsorption, with enzymatic dysfunction observed at the brush border, along with leak flux and anion secretion.[10, 9] Vomiting is related to virus-mediated changes in gastric motility and delayed gastric emptying. Notably, no histopathologic lesions can be identified in the gastric mucosa of infected patients.[11] Noroviruses do not invade the colon, so fecal leukocytes are typically absent, and hematochezia is rare.

Previous
Next

Epidemiology

Frequency

United States

The Centers for Disease Control and Prevention (CDC) report that noroviruses account for more than 96% of all viral gastroenteritis cases, with at least 23 million infections occurring annually in the United States. Worldwide, noroviruses cause up to half of all outbreaks of gastroenteritis, making this the most common cause of sporadic diarrhea in community settings.[12]

According to surveillance reports prepared by CDC's OutbreakNet team, in 2006, 1,270 reported foodborne outbreaks resulted in 27,634 illnesses and 11 deaths. Among these 1,270 outbreaks, 621 had a single confirmed cause that was most often norovirus (54% of outbreaks), followed by Salmonella species (18% of outbreaks).[13]

Outbreaks have been reported in restaurants, health care facilities, schools, resorts, cruise ships, military ships, and barracks. Viral transmission occurs year-round, with a higher incidence of disease in winter months in temperate climates.[14]

International

Data regarding outbreaks in developing nations are not well quantified, but the outbreak rate in other industrial nations is similar to that of the United States.

Mortality/Morbidity

Norovirus gastroenteritis typically lasts 24-72 hours, with remission occurring without sequelae. Death is extremely rare, except in individuals particularly vulnerable to profound volume depletion.

Age

Norovirus gastroenteritis can occur in individuals of all ages. Studies using norovirus recombinant antigen have suggested an increase in antibody prevalence with advancing age. In one study, the prevalence of norovirus immunoglobulin G (IgG) rose during school-aged years, reaching a peak of 70% in persons aged 11-16 years.[15] It should be noted, however, that not all infected individuals sustain detectable antibody responses.

Previous
 
 
Contributor Information and Disclosures
Author

Zartash Zafar Khan, MD  Infectious Disease Consultant

Zartash Zafar Khan, MD is a member of the following medical societies: American College of Physicians, American Medical Association, Infectious Diseases Society of America, and International Society for Infectious Diseases

Disclosure: Nothing to disclose.

Coauthor(s)

Mark Martin Huycke, MD  Professor of Medicine, Infectious Diseases Section, University of Oklahoma Health Sciences Center; Chief, Medical Service, Department of Veterans Affairs Medical Center, Oklahoma City

Mark Martin Huycke, MD is a member of the following medical societies: American Association for Cancer Research, American Association for the Advancement of Science, American College of Physicians, American Federation for Medical Research, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Todd S Wills  MD, Associate Professor, Department of Medicine, Division of Infectious Disease and International Medicine, Program Director, Infectious Disease Fellowship Program, University of South Florida College of Medicine

Todd S Wills is a member of the following medical societies: Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Michelle A Jaworski  MD, Consulting Staff, Midland Orthopedic Associates

Disclosure: Nothing to disclose.

Specialty Editor Board

Joseph Richard Masci, MD  Professor of Medicine, Professor of Preventive Medicine, Mount Sinai School of Medicine; Director of Medicine, Elmhurst Hospital Center

Joseph Richard Masci, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, Association of Professors of Medicine, and Royal Society of Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Richard B Brown, MD, FACP  Chief, Division of Infectious Diseases, Baystate Medical Center; Professor, Department of Internal Medicine, Tufts University School of Medicine

Richard B Brown, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Chest Physicians, American College of Physicians, American Medical Association, American Society for Microbiology, Infectious Diseases Society of America, and Massachusetts Medical Society

Disclosure: Nothing to disclose.

Eleftherios Mylonakis, MD  Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital

Eleftherios Mylonakis, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Society for Microbiology, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

References
  1. www.ncbi.nlm.nih.gov/ICTVdb/ICTVdB/00.012.0.03.htm [database online]. http://www.ictvonline.org/index.asp: 2002.

  2. Shoemaker GK, van Duijn E, Crawford SE, Uetrecht C, Baclayon M, Roos WH, et al. Norwalk virus assembly and stability monitored by mass spectrometry. Mol Cell Proteomics. Aug 2010;9(8):1742-51. [Medline]. [Full Text].

  3. Jiang X, Wang M, Wang K, Estes MK. Sequence and genomic organization of Norwalk virus. Virology. Jul 1993;195(1):51-61. [Medline].

  4. Ando T, Noel JS, Fankhauser RL. Genetic classification of "Norwalk-like viruses.. J Infect Dis. May 2000;181 Suppl 2:S336-48. [Medline].

  5. Zheng DP, Ando T, Fankhauser RL, Beard RS, Glass RI, Monroe SS. Norovirus classification and proposed strain nomenclature. Virology. Mar 15 2006;346(2):312-23. [Medline].

  6. Donaldson EF, Lindesmith LC, Lobue AD, Baric RS. Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations. Immunol Rev. Oct 2008;225:190-211. [Medline].

  7. Huang P, Farkas T, Marionneau S, Zhong W, Ruvoën-Clouet N, Morrow AL, et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis. Jul 1 2003;188(1):19-31. [Medline].

  8. Schreiber DS, Blacklow NR, Trier JS. The mucosal lesion of the proximal small intestine in acute infectious nonbacterial gastroenteritis. N Engl J Med. Jun 21 1973;288(25):1318-23. [Medline].

  9. Troeger H, Loddenkemper C, Schneider T, Schreier E, Epple HJ, Zeitz M, et al. Structural and functional changes of the duodenum in human norovirus infection. Gut. Aug 2009;58(8):1070-7. [Medline].

  10. Acute infectious nonbacterial gastroenteritis: etiology and pathogenesis. Ann Intern Med. Jun 1972;76(6):993-1008. [Medline].

  11. Widerlite L, Trier JS, Blacklow NR, Schreiber DS. Structure of the gastric mucosa in acute infectious bacterial gastroenteritis. Gastroenterology. Mar 1975;68(3):425-30. [Medline].

  12. Atmar RL, Estes MK. The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am. Jun 2006;35(2):275-90, viii. [Medline].

  13. Norovirus and Salmonella were Leading Causes of Foodborne Disease Outbreaks in 2006. Available at http://www.cdc.gov/media/pressrel/2009/r090611.htm.

  14. Mounts AW, Ando T, Koopmans M, Bresee JS, Noel J, Glass RI. Cold weather seasonality of gastroenteritis associated with Norwalk-like viruses. J Infect Dis. May 2000;181 Suppl 2:S284-7. [Medline].

  15. Parker SP, Cubitt WD, Jiang XJ, Estes MK. Seroprevalence studies using a recombinant Norwalk virus protein enzyme immunoassay. J Med Virol. Feb 1994;42(2):146-50. [Medline].

  16. Rockx B, De Wit M, Vennema H, Vinjé J, De Bruin E, Van Duynhoven Y, et al. Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis. Aug 1 2002;35(3):246-53. [Medline].

  17. Guerrant RL, Shields DS, Thorson SM. Evaluation and diagnosis of acute infectious diarrhea. Am J Med. Jun 28 1985;78(6B):91-8. [Medline].

  18. Tian P, Mandrell R. Detection of norovirus capsid proteins in faecal and food samples by a real time immuno-PCR method. J Appl Microbiol. Mar 2006;100(3):564-74. [Medline].

  19. Brinker JP, Blacklow NR, Jiang X, Estes MK, Moe CL, Herrmann JE. Immunoglobulin M antibody test to detect genogroup II Norwalk-like virus infection. J Clin Microbiol. Sep 1999;37(9):2983-6. [Medline].

  20. Boxman I, Dijkman R, Verhoef L, Maat A, van Dijk G, Vennema H, et al. Norovirus on swabs taken from hands illustrate route of transmission: a case study. J Food Prot. Aug 2009;72(8):1753-5. [Medline].

  21. Cheng VC, Tai JW, Ho YY, Chan JF. Successful control of norovirus outbreak in an infirmary with the use of alcohol-based hand rub. J Hosp Infect. Aug 2009;72(4):370-1. [Medline].

  22. Liu P, Yuen Y, Hsiao HM, Jaykus LA, Moe C. Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands. Appl Environ Microbiol. Jan 2010;76(2):394-9. [Medline]. [Full Text].

  23. Mattner F, Sohr D, Heim A, Gastmeier P, Vennema H, Koopmans M. Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect. Jan 2006;12(1):69-74. [Medline].

  24. Ito S, Takeshita S, Nezu A, Aihara Y, Usuku S, Noguchi Y, et al. Norovirus-associated encephalopathy. Pediatr Infect Dis J. Jul 2006;25(7):651-2. [Medline].

  25. Sugimoto T, Ogawa N, Aoyama M, Sakaguchi M, Isshiki K, Kanasaki M, et al. Haemolytic uraemic syndrome complicated with norovirus-associated gastroenteritis. Nephrol Dial Transplant. Jul 2007;22(7):2098-9. [Medline].

  26. Blacklow NR, Greenberg HB. Viral gastroenteritis. N Engl J Med. Jul 25 1991;325(4):252-64. [Medline].

  27. Centers for Disease Control and Prevention (CDC). Multisite outbreak of norovirus associated with a franchise restaurant--Kent County, Michigan, May 2005. MMWR Morb Mortal Wkly Rep. Apr 14 2006;55(14):395-7. [Medline].

  28. Centers for Disease Control and Prevention (CDC). Norovirus outbreak among evacuees from hurricane Katrina--Houston, Texas, September 2005. MMWR Morb Mortal Wkly Rep. Oct 14 2005;54(40):1016-8. [Medline].

  29. Centers for Disease Control and Prevention (CDC). Outbreaks of gastroenteritis associated with noroviruses on cruise ships--United States, 2002. MMWR Morb Mortal Wkly Rep. Dec 13 2002;51(49):1112-5. [Medline].

  30. [Guideline] DuPont HL. Guidelines on acute infectious diarrhea in adults. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. Nov 1997;92(11):1962-75. [Medline].

  31. Graham DY, Jiang X, Tanaka T. Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis. Jul 1994;170(1):34-43. [Medline].

  32. Greenberg HB, Valdesuso J, Yolken RH. Role of Norwalk virus in outbreaks of nonbacterial gastroenteritis. J Infect Dis. May 1979;139(5):564-8. [Medline].

  33. Jiang X, Wang M, Graham DY. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol. Nov 1992;66(11):6527-32. [Medline].

  34. Jääskeläinen AJ, Maunula L. Applicability of microarray technique for the detection of noro- and astroviruses. J Virol Methods. Sep 2006;136(1-2):210-6. [Medline].

  35. Kaplan JE, Gary GW, Baron RC. Epidemiology of Norwalk gastroenteritis and the role of Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann Intern Med. Jun 1982;96(6 Pt 1):756-61. [Medline].

  36. Moe CL, Gentsch J, Ando T. Application of PCR to detect Norwalk virus in fecal specimens from outbreaks of gastroenteritis. J Clin Microbiol. Mar 1994;32(3):642-8. [Medline].

Previous
Next
 
Hematoxylin and eosin stain of duodenal epithelium.
The norovirus genomic structure and capsid domains.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.